News in the Life Sciences Industry

STOCKHOLM, March 20, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it has started a new preclinical drug project, TrkA-NAM, which is based on the company's research platform NeuroRestore.

LINKÖPING, Sweden, March 20, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

STOCKHOLM, March 20, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that preclinical findings support the positioning of its drug candidate T20K as a prophylactic agent for the treatment of multiple sclerosis (MS). This indicates that the substance... Read more ››

LUND, Sweden, March 19, 2019 /PRNewswire/ -- The shareholders of BioInvent International AB (publ), Reg. No 556537-7263, are hereby invited to attend the Annual General Meeting (the "AGM") to be held at 4 p.m., Thursday 25 April 2019 at Elite Hotel Ideon on Scheelevägen 27 in Lund, Sweden.

STOCKHOLM, March 15, 2019 /PRNewswire/ -- Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") (OMX: MOB) today held an Extraordinary General Meeting in the Company's premises in Bromma. The Extraordinary General Meeting resolved as set out below.

STOCKHOLM, March 13, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company, today announced the company plans to evaluate a possible relisting of its shares from Nasdaq First North Premier to Nasdaq Stockholm's main market during 2019.... Read more ››